Archives of Psychiatric Nursing
Volume 20, Issue 4 , Pages 166-174 , August 2006

Stages of Change for Psychotropic Medication Adherence and Substance Cessation

  • Deborah S. Finnell

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Deborah S. Finnell, DNS, APRN, BC, NPP, CARN, AP, The State University of New York, University at Buffalo School of Nursing, 1030 Kimball Tower, 3435 Main Street, Buffalo, NY 14214-3079.
    • ,
  • Frederick H. Osborne

References 

  1. American Society of Addiction Medicine . Patient placement criteria for the treatment of substance-related disorders. 2nd ed.. Chevy Chase, MD: Author; 1996;
  2. Belding MA, Iguchi MY, Lamb R. Stages and processes of change as predictors of drug use among methadone maintenance patients. Experimental and Clinical Psychopharmacology. 1997;5(1):65–73
  3. Bellack AS, DiClemente CC. Treating substance abuse among patients with schizophrenia. Psychiatric Services. 1999;50(1):75–80
  4. Carey KB, Purnine DM, Maisto SA, Carey MP. Enhancing readiness-to-change substance abuse in persons with schizophrenia: A four-session motivation-based intervention. Behavior Modification. 2001;25(3):331–384
  5. Carey KB, Purnine DM, Maisto SA, Carey MP. Correlates of stages of change for substance abuse among psychiatric outpatients. Psychology of Addictive Behaviors. 2002;16(4):283–289
  6. Connors GJ, Donovan DM, DiClemente CC. Substance abuse treatment and the stages of change: Selecting and planning interventions. New York: Guilford Press; 2001;
  7. Cook CL, Perri M. Single-item vs. multiple-item measures of stage of change in compliance with prescribed medications. Psychological Reports. 2004;94(1):115–124
  8. Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, et al. Implementing dual diagnosis services for clients with severe mental illness. Psychiatric Services. 2001;52(4):469–476
  9. Drake RE, Mueser KT. Psychosocial approaches to dual diagnosis. Schizophrenia Bulletin. 2000;26(1):105–118
  10. Finnell DS. Monthly medication journal: Taking an active role in managing your mental health. Rochester, NY: Merlin International; 2005;
  11. Finnell, D.S. (2005b). A stage-based medication program. Unpublished manuscript.
  12. Haynes RB, McDonald H, Garg AX, Montague P. Interventions for helping patients to follow prescriptions for medications. (Cochrane review) In: The Cochrane database of systematic reviews. 2:Ovid Evidence-Based Medicine Reviews: Cochrane database of systematic reviews; 2002;Retrieved December 5, 2005 from
  13. Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL, Davis JM, Lewis DA. Predicting the “revolving door” phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. American Journal of Psychiatry. 1995;152(6):856–861
  14. Hunt GE, Bergen J, Bashir M. Medication compliance and comorbid substance abuse in schizophrenia: Impact on community survival 4 years after a relapse. Schizophrenia Research. 2002;54(3):253–264
  15. Kemppainen JK, Buffum M, Wilke G, Kestner M, Zappe C, Hopkins R, et al. Psychiatric nursing and medication adherence. Journal of Psychosocial Nursing. 2003;41(2):38–51
  16. Kessler R, Nelson D, McGonagle K, Edlund M, Frank R, Leaf P. The epidemiology of co-occurring addictive and mental disorders: Implications for prevention and service utilization. American Journal of Orthopsychiatry. 1996;66(1):17–31
  17. Loffler W, Killian R, Tourmi M, Angermeyer MC. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry. 2003;36(3):105–112
  18. McLellan A, Luborsky L, O'Brien C, Woody G. An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disorders. 1980;168(1):26–33
  19. Minkoff K. Developing standards of care for individuals with co-occurring psychiatric and substance use disorders. Psychiatric Services. 2001;52(5):597–599
  20. National Institute on Alcoholism and Alcohol Abuse (NIAAA) . What you don't know can harm you. (NIH Publication No. 99-4323) Washington, DC: U.S. Government Printing Office; 1999;
  21. Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J, Weiden PJ. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services. 2000;51(2):216–222
  22. Osher FC, Drake RE. Reversing a history of unmet needs: approaches to care for persons with co-occurring addictive and mental disorders. American Journal of Orthopsychiatry. 1996;66(1):4–11
  23. Owen RR, Fischer EP, Booth BM, Cuffel BJ. Medication noncompliance and substance abuse among patients with schizophrenia. Psychiatric Services. 1996;47(8):853–858
  24. Prochaska JO, DiClemente CC. Stages and processes of self-change of smoking: Toward an integrative model of change. Journal of Consulting and Clinical Psychology. 1983;51(3):390–395
  25. Prochaska JO, DiClemente CC. The Transtheoretical approach: Crossing traditional boundaries of treatment. Homewood, IL: Dow Jones-Irwin; 1984;
  26. Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. American Journal of Health Promotion. 1997;12(1):38–48
  27. Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, et al. Stages of change and decisional balance for 12 problem behaviors. Health Psychology. 1994;13(1):39–46
  28. Rand CS, Weeks K. Measuring adherence with medication regimens in clinical care and research. In:  Shumaker SA,  Schron EB,  Okene JK,  McBee WL editor. The handbook of health behavior change. New York: Springer Publishing; 1998;p. 114–132
  29. Ruscher SM, de Wit R, Mazmanian D. Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatric Services. 1997;48(1):82–85
  30. Sobell LC, Sobell MB. Timeline follow-back: A technique for assessing self-reported alcohol consumption. In:  Litten R,  Allen J editor. Measuring alcohol consumption: Psychosocial and biochemical methods. Totawa, NJ: Humana Press; 1992;p. 41–72
  31. Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, et al. Stages of change for adherence with medication regimens for chronic disease: Development and validation of a measure. Clinical Therapeutics. 2000;22(7):858–871
  32. Yavinsky C, O'Brien C, Reagan L, Staff I, Maljanian R, Jaroszewski E. The effect of a specialized RN intervention designed to maximize patient–provider relationships on adherence to anti-depressant medication. New Haven, CT: Yale University School of Nursing Yale University; 2003;Retrieved on March 29, 2005, from the World Wide Web: http://nursing.yale.edu/hcr/projects/yavinsky.htm

PII: S0883-9417(06)00029-X

doi: 10.1016/j.apnu.2005.12.006

Archives of Psychiatric Nursing
Volume 20, Issue 4 , Pages 166-174 , August 2006

Article Tools

* Image Usage & Resolution